Anja Lundgren Mortensen

Artiklar

Article: NUCLEAR MEDICINE AND BIOLOGY. 2025;144:109012
Affinity maturation and optimization of CD44v6-targeting antibodies for molecular radiotherapy
Mortensen ACL; Hofstrom C; Persson H; Dahllund L; Frejd FY; Nestor M
Article: HELIYON. 2023;9(12):e22594
Utilizing CD44v6 and V600EBRAF-mutation for in vitro targeted combination therapy of thyroid carcinomas.
Mortensen ACL; Imgenberg-Kreuz J; Spiegelberg D; Botling J; Nestor M
Article: SCIENTIFIC REPORTS. 2023;13(1):20648
Selection, characterization and in vivo evaluation of novel CD44v6-targeting antibodies for targeted molecular radiotherapy
Mortensen ACL; Berglund H; Segerstroem L; Walle M; Hofstrom C; Persson H; Nygren P-A; Nilvebrant J; Frejd FY; Nestor M
Article: SCIENTIFIC REPORTS. 2023;13(1):16844
Combination therapy of tyrosine kinase inhibitor sorafenib with the HSP90 inhibitor onalespib as a novel treatment regimen for thyroid cancer
Mortensen ACL; Berglund H; Hariri M; Papalanis E; Malmberg C; Spiegelberg D